BEAT Heartbeam Forecast, Technical & Fundamental Analysis
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting... Show more
BEAT is expected to report earnings to fall 25.00% to -9 cents per share on August 06
Q2'26
Est.
$-0.09
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.46
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -11 cents, beating the estimate of -14 cents. With 555.76K shares outstanding, the current market capitalization sits at 43.13M.
A.I. Advisor
published General Information
General Information
a wireless medical technology company, which focuses on the delivery of health information
A.I.dvisor indicates that over the last year, BEAT has been loosely correlated with SNOW. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BEAT jumps, then SNOW could also see price increases.
Momentum Indicator for BEAT turns negative, indicating new downward trend
BEAT saw its Momentum Indicator move below the 0 level on May 27, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In of the 81 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for BEAT turned negative on June 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BEAT entered a downward trend on June 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BEAT's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAT advanced for three days, in of 188 cases, the price rose further within the following month. The odds of a continued upward trend are .
BEAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BEAT's P/B Ratio (68.027) is very high in comparison to the industry average of (7.560). BEAT has a moderately low P/E Ratio (0.000) as compared to the industry average of (50.229). BEAT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.180). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (5.686).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BEAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.
